LH vs VIR · P/E 23, rev $7.27B vs rev $238.9M
Laboratory Corporation of America Holdings (LH) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
LH currently screens at market cap $21.07B and trailing P/E 22.8. VIR currently screens at market cap $1.45B.
Not investment advice. Open the LH and VIR stock pages for the full models.
Not investment advice.